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Abstract
Informed consent process is crucial in any research. The consent is meaningful
only when the subject is capable of using disclosed information in deciding whether to
participate in a research study. Decision-making capacity might change in psychiatric
patients during the informed consent process. Therefore, there may be some elements
which are neglected during the informed consent process in psychiatric research. The
purpose of this research study was to determine the perceptions of physicians about what
elements of informed consent might be neglected in psychiatric research and what
additional elements might be included that would improve the informed consent process
for psychiatric trials. There were limitations in this study; response rate was very low.
Other researchers have also found very low response rates in physician surveys. Further
studies should be done with a larger population having wide range of healthcare
professionals who have had experience in psychiatric clinical trials.
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Chapter 1: Introduction
According to ICH GCP (1996), “Informed consent is the process by which a
subject voluntarily confirms his or her willingness to participate in a particular trial, after
having been informed of all aspects of the trial that are relevant to the subject’s decision
to participate.” Also, documentation of informed consent is done by means of a written,
signed, and dated informed consent form (ICH GCP, 1996).
The consent is meaningful only when the subject is capable of using disclosed
information in deciding whether to participate in research or not. According to Dunn
(2006), a person is capable of making a decision only when he/she is able to:


Understand, use and appreciate the information



Apply it to their situation



Be consistent in their decision

Cognitive impairment and certain psychiatric or neurological diseases (e.g.,
schizophrenia, Alzheimer’s, severe depression) may affect the decision-making capacity.
In addition, some situational factors like complexity of disclosed information, and
manner of disclosure can also affect the decision-making capacity.
According to Stanley Milgram (1974), “The social psychology of the century reveals
a major lesson: often it is not so much the kind of person a man is as the kind of situation
in which he finds himself that determines how he will act.”
Milgram’s experiment is a classic in psychology that demonstrates the dangers of
obedience. The experiment demonstrates that situation plays a stronger role than
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personality factors in obedience. The psychologists argue that obedience depends on both
internal and external factors such as the overall temperament of the person and his
personal beliefs. In Milgram’s experiment, subjects are deceived to achieve the research
goals and deception of research subjects is essential to prevent subjects from knowing the
researcher’s insight (McLeod, 2007).
However, it is very important to stick to the ethical code, as we are dealing with
humans, and deception of subjects is not correct in all situations. (e.g., psychological
disability is a situation where people are not in a position to take correct decisions on
their own. Therefore, psychological disability should not be a cause for deception.)
Hence, a deception results in violation of individual rights to choose to participate, and it
leads to distrust of psychology in community (McLeod, 2007).
According to Appelbaum (1982), description of experimental methods (e.g.,
randomization, blinding) to subjects was often neglected during informed consent process
in psychiatric research. This negligence leads to the gaining of informed consent from
psychiatric patients by deception, which causes distress to patients (McLeod, 2007). In
addition, in many psychiatric trials, the subjects are primarily treated to advance the goals
of the researcher rather than as a person who is respected for his/her own sake (Bernard,
2010).
This research study aimed to determine the perceptions of physicians regarding what
elements of informed consent might be neglected in the psychiatric research and what
additional elements might be included that would improve the informed consent process
for psychiatric trials. The perceptions of physicians who have done psychiatric clinical
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trials were to be compared with the work they have actually done. This comparison
would have determined if any elements that they identified as their perceptions are
neglected by them in their real work. This exercise would have given an idea about
whether the elements are actually neglected and could be used to support the hypotheses
of the research. If the results of comparison showed congruity between psychiatrists’
perceptions and their actual work, then this might have altered the informed consent
process for psychiatric patients and included new elements in the informed consent.
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Chapter 2: Background
According to Bernard (2010), as per the ethical concerns, restricting subject
participation in psychiatric trials is one way to protect them.
According to the Center for Disease Control and Prevention (CDC) statistics,
more than 1 out of 20 Americans 12 years of age and older are suffering from serious
depression (Depression, n.d.), and nearly 40% of adults in 35 states are suffering from
serious psychological disorders (Non-specific Psychological Distress, n.d.).
There has been a drastic increase in the mental illness rate in United States;
research with psychiatrically ill subjects is also facing increased scrutiny ("America's
State of Mind: A Report by Medco,” 2011).
There has been an increase in the use of medications for mental health by both
men and women in 2010 when compared to 2001 (Fig.1). There has also been an increase
in the use of medications for mental health by boys as well as by the girls in 2010 when
compared to the usage of medications for mental health in 2001 ("America's State of
Mind: A Report by Medco,” 2011).
As shown in Figure 2, there was an increase in the use of ADHD (Attention Deficit / Hyperactivity Disorder) medications from 2001 to 2010. Women have surpassed
men in the usage of medications for ADHD in 2010 compared to 2001. There has also
been a continuous increase in the use of medications for ADHD from 2001 to 2010
("America's State of Mind: A Report by Medco,” 2011).
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Figure 1. Percent of Population Using Mental Health Medications
("America's State of Mind: A Report by Medco,” 2011)

Figure 2. Percent of Americans Ages 20 - 44 on ADHD Medications over
Time ("America's State of Mind: A Report by Medco,” 2011)

5

Informed consent in Psychiatric Research
Psychiatric illness should not prevent a patient from understanding what he/she
has consented to, choosing whether to participate or not, having the ability to
communicate his/her consent, and accepting the need for a medical intervention (Van
Staden, 2003). A person should be competent to give his/her consent. Malhotra (2007)
stated “Competency refers to some minimal, mental capacity required to perform a
specific, legally recognized act or to assume some legal role.”
According to the U.S Supreme Court, recruiting psychiatric patients into research
without verifying their competency is violating due process rights (Kitamura, 1999).
Assessing subject competency is a challenging task. If a competent patient is assessed as
incompetent, his/her rights to give informed consent are violated, and if an incompetent
patient is assessed as competent, his/her rights to be protected from mental health law are
violated. Persons to be determined as incompetent for one condition (financial affairs)
may be competent to make a decision about participation in research. Moreover,
decision-making capacity is protocol-specific and situational specific (Kitamura, 1999).
According to the National Center for Ethics (2002), “A patient who lacks capacity
to make one decision does not necessarily lack the ability to make all decisions.” For
example, a dementia patient can make a decision, such as whether to take a simple
antibiotic treatment for urinary tract infection, but at the same time he/she cannot decide
about a complex neurosurgical procedure with many risks and anticipated benefits.
Therefore, each decision must be assessed separately while evaluating the decisionmaking capacity of patients (National Center for Ethics, 2002).
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The following factors can help the researcher to determine that the research
subject is competent, if they satisfy all of the following (Cady, 2010):


Patient is aware of surroundings



Patient can understand the research information provided



Patient is able to make a decision by himself/herself based on what is best for
him/her



Patient is able to ask a question about the information provided in informed
consent



Patient is able to support his/her decision to refuse to participate in research

Components of Decision-Making Capacity
“Capacity is the dimensional quality of a person” (Karlawish, 2008). Decisional
capacity is evaluated under four subparts (Zalta, 2011):
Understanding: This is the first and most basic element required for giving consent.
This is the ability to grasp and understand the information provided in the informed
consent form.
Appreciation: This is the ability of the decision-maker to determine that this is his or
her decision to make and also to evaluate the subject’s ability to appreciate the nature
and potential alternatives for the future.
Reasoning: This is to determine the ability of the subject to think logically about the
treatment options available, compare options, and infer the consequences of treatment
options.

7

Informed consent in Psychiatric Research
Choice: Many authors do not consider choice as an element of capacity. Choice is
just the state of expressing their decision. Even a person with a good understanding,
appreciation, and reasoning skills cannot express his/her decision if he/she is
unconscious. Therefore, expressing choice is added to the list of elements of capacity
as choice may compromise the decisional capacity.
Tools Used to Assess the Decision-Making Capacity
According to the National Center for Ethics (2002), there is no standard tool to assess
the decision-making capacity in spite of many tools developed. Among the tools
developed, the Mac CAT-CR, Informed Consent Survey and Vignette methods are
designed to measure all four of the subparts of capacity, as other tools measure
understanding in most cases (Dunn, 2006).
1) MacArthur Competence Assessment Tool for Clinical Research (Mac CAT-CR)
This is one of the most commonly used tools to assess the decision-making capacity
of patients. This tool is designed by Grisso and Appelbaum (Grisso, 2001). Dunn (2006)
stated that Mac CAT-CR is a semi-structured interview tool. It is designed to evaluate the
four subparts of capacity (understanding, appreciation, reasoning and choice). It is mainly
used to evaluate dementia, depression, and schizophrenia patient populations. It takes 1530 min to complete and requires training to administer and interpret results.
According to “Guide to Informed Decision-making in Healthcare” (2012), “There are
no cut off scores to differentiate between capacity and incapacity, but the tool provides
insight into the various abilities as relevant to decision making capacity.”
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For Mac CAT-CR, a manual is also provided which explains the scoring guidelines
based on which scores are given during the interview, and subsequent follow-up
questions are raised based on scores. Hence, a little vigorous training is required to
administer this test.
2) Vignette method
Vignettes are the artworks that assist explanation. Different vignettes are proposed as
per the situation (what type of trial), and the decision-making capacity is assessed on the
featured interview after viewing the vignette. Different questions such as “What might be
the problem?” and “What advice would you give to problem described?” are put through
to determine the subjects’ decision-making capacity. This is used in Alzheimer’s Disease
(Clare, 2012).
Clare (2012) also stated that vignettes are created with one main character (either
male or female). The patients are given opposite gender vignettes to prevent feelings of
distress and to make subjects feel it was not related to them.
3) Informed Consent Survey
This is the other acceptable tool to test the decision-making of the mentally impaired
subjects. This is a structured interview which involves a series of questions about the
information provided in the Informed Consent. Patients are asked different types of
questions to determine their understanding levels, and the information is repeated if they
fail to answer the questions (Dunn, 2006).
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Informed Consent Process in Psychiatric Research
Usher (1998) stated that recommended use of psychiatric medications in psychiatric
settings is an excellent example where key elements (e.g., autonomy, specificity and
competency) of informed consent process are neglected with regard to treatment. In
addition, the regulations for the informed consent process with psychiatric patients are
inadequate, and regulations provide exceptionally limited guidance, which is inadequate
for all kinds of situations related to consent process for psychiatric patients (Gupta,
2012).
Elements of Informed consent
According to "The Belmont Report: Ethical Principles and Guidelines for the
Protection of Human Subjects of Research" (1979), informed consent process is the
combination of three elements.
Information: The most valuable part in informed consent, it includes research
procedures, research purpose, anticipated benefits and risks, alternative procedures
(any therapy involved), subject opportunity to ask questions, statement that states
subject can withdraw from study at any time, subject recruitment process, who is
responsible for research, and so on.
Comprehension: Presenting the information during the informed consent process in
an understandable way to the subjects.
Voluntariness: Informed consent is obtained voluntarily without any coercion and
undue influence.
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The three elements should be satisfied to obtain informed consent. A special care
should be taken for psychiatric patients to satisfy these three elements. According to
Appelbaum (1982), information about research is not provided in full length to the
subjects, especially about the randomization techniques. As per the observation from two
different research projects, approximately 69% of subjects had no idea about the double
blind technique used in their project (Appelbaum, 1982). Therefore, Appelbaum (1982)
indicated this as therapeutic misconception and deception of subjects in obtaining the
consent.
Informed consent can be a benefit to subjects with decisional impairment, if it is
explained clearly and adequately to the subjects. Researchers should take necessary steps
to make the informed consent process fruitful.
According to Davies (2001), there is a belief that psychiatric research is
recommended as part of patient treatment for the benefits of researchers instead of the
improvement of treatment options for the patients. For that reason, there is a need to
create new conditions for patients urged to participate in psychiatric trials. This will in
turn benefit the psychiatric research. An alternative and tailored informed consent process
should be developed for psychiatric research.
A patient with psychiatric disorder means that he/she is not completely incompetent.
Some can understand, some can appreciate, and some can make a choice whether to
participate or not. According to Gupta (2012), many studies indicated that subjects with
mental disorders are incompetent in one or two indices of decisional capacity, mostly
understanding and reasoning. As a result, tailoring informed consent according to the
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subject’s cognitive deficits (e.g., memory, language, attention, and awareness) ensures
that the subject can provide adequate and reasonable consent.
Appropriate approaches for reasonable consent are as follows (Gupta, 2012):


Detailed discussion and presentation of study



Simplified language



Information disclosure in small consecutive pieces



Repeated information



Enough time and opportunity to ask questions

Consequently, one should assess what the impaired capacity indices of the subjects
are and customize the informed consent process according to them.
An informed consent process in psychiatric research may be represented at in Figure
3 (Church, 2007).

12

Informed consent in Psychiatric Research

Screening (To determine subject impaired indices based
on the screening results)

Proceed to Informed
consent process and
document it.

Proceed to formal capacity
assessment and based on
assesment

Exclude form
study or go for
proxy
Proceed to Informed consent
process and document it.

Figure 3. Informed Consent Process in Psychiatric Research (Church, 2007)
The process as described by Church (2007) includes:
Initial Screening


Initial screening is done before the actual informed consent process.



This is a general and informal screening to determine subjects’ impaired
indices (e.g., understanding, reasoning, appreciation and choice). These
impairments can affect the subject decision-making capacity. Hence it is
advisable to determine these impaired indices before assessing the decisionmaking capacity.
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In initial screening subjects are explained about the procedures, risks, and
benefits of the trial in brief.



Subject's impaired indices are determined in the initial screening by
questioning about risks, anticipated benefits of research, procedures and
research purpose, and so on. Based on the screening results we can determine
in which particular indices subject is impaired and whether this impaired
indices will affect the decision-making capacity of the subject.

After Screening


After screening, if the subject is determined to have adequate consent
capacity, then proceed to the actual consent process by taking all possible
steps that support the subject’s decision-making capacity; finally, physicians
need to document the informed consent process.



If subject is determined to have a problem in understanding complex
information, then physicians should take necessary steps to make the
information simple and understandable which can help subjects to make
decisions on their own.



According to Church, there is a need to give very careful attention in writing
informed consent for psychiatric patients. Informed Consent should be very
simple, uniformly structured, and include shorter sentences and simple words
and be in simple format.



After screening, even after providing the support to understand, if the subject
is suspected to be incompetent, the formal capacity assessment is begun. Any
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capacity assessment tool (Mac CAT-CR, Vignette etc.) is used to determine
decision-making capacity.


After capacity assessment, if subject is determined to have adequate consent
capacity, the formal consent process is conducted and documented.



If the subject is again determined to be incompetent, the subject should be
expelled from the trial, or Legal Authorized Representative (LAR) consent is
used to enroll to the clinical trial.

Persons with psychological disorders are not always incompetent. The subject may
retain competency during research. Hence, the informed consent should be made as an
ongoing process throughout the research (Church, 2007).
Legally Authorized Representative Consent or Proxy or Surrogate Consent
A person who may consent on behalf of another to participate in research is referred
as proxy or surrogate (Saks, 2008). Regardless of a code of ethics and statements by
professional societies, there are no clear guidelines or conditions for proxy consent.
However, current federal regulations allow proxy consent under the permission of
Legally Authorized Representative (LAR), “an individual or judicial or other body
authorized under applicable law to consent on behalf of the prospective subject to the
subject’s participation in the procedures involved in the research” [45CFR46.102(c)]. The
issue is who can be LAR and whether the laws of the jurisdiction of the state where they
are conducting research confirm the LAR. As per the federal regulations, each state has
its own laws for research involving mentally-impaired adults.
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Saks (2008) stated that courts, guardians, people with durable power of attorney for
health care, and family members were accepted as proxies by different states. In general,
family members are preferred as proxies as they are more concerned about the subject
and know best about the subject. In addition, taking family members as proxy is more
time-saving and cost-effective for the researchers.
A person should be legally authorized to give proxy consent. This authorization is
attained under applicable state law. Many states have no clear, applicable laws that
explain about the proxy consent. In those states, family members or any person who has
authority to provide proxy consent for medical treatment or medical procedure itself
provides proxy consent to research also if that research involves the same medical
procedure as in treatment (Saks, 2008).
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Chapter 3: Thesis Statement
1) Are elements of informed consent process neglected in psychiatric research?
Have physicians who have done psychiatric clinical trials neglected any of the
elements in the informed consent process? The question will be used to compare the work
done in the real world to the physician’s perception. If the outcomes obtained are in
support of hypotheses, then this study can be used to identify necessary further research
on the informed consent process in psychiatric trials and make changes in the consent
process.
Based on published literature, the following are some possible findings for the
elements that are being neglected in informed consent process in psychiatric research:


Information provided in informed consent (especially experimental

methods): The physicians neglect to explain to the subjects in psychiatric
research about the experimental procedure (e.g., randomization, blinding, and
possible risks) in research as they think that the subject cannot comprehend.


Comprehension of informed consent: In psychiatric research, physicians

should focus on the comprehension of the informed consent process as this gives
subjects a better understanding about the trial. They need to repeat the
information repeatedly until subject understands. The physicians might neglect to
do this, as they think the subject is mentally impaired and unable to understand
despite recurring explanations.
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Failure to test the decision-making capacity of the patients: Physicians

assume that patients with psychiatric illness are mentally impaired and neglect to
test their decision-making capacity as it is time intensive and involves additional
procedures.


Investigators delegate informed consent process to lower level assistant:

From the summary of literature review, it was determined that investigators are
not involved in the informed consent process of psychiatric research because they
delegate that responsibility to their assistants.


Failure to explain to subjects the difference between research and

treatment: The subject has a right to know the difference as every research
cannot be regarded as treatment. The research procedures are different, and every
subject in the research may not receive the drug as the trial may be placebocontrolled. In psychiatric research they may neglect to explain the subject about
the research procedure as they think the subject is not competent to understand
that information. Hence, the subject should be informed about the research
procedures and explained the anticipated risks and benefits.


Offer explanations in language difficult to understand by patients: Every

subject in the research may not have English as his or her primary language, and
many subjects who even clearly understand and speak the English language may
still have difficulty in understanding research language. Offering an explanation
of complex experimental procedures to non-English speaking subjects with
mental disabilities creates fear of involvement and further misunderstanding.
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2) What are the perceptions of physicians (who have participated in psychiatric
trials versus the non-participants?) about the informed consent process in
psychiatric research?
3) What elements of informed consent are to be tailored or what elements are to be
included to enhance the informed consent process in psychiatric research?
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Chapter 4: Methodology
Sample Population
This research has been conducted to determine the perceptions of the physicians
about the informed consent process in psychiatric research. A well designed electronic
survey was developed to determine the perceptions of the study population. The
population of interest for this study is physicians. The Michigan Psychiatric Society was
selected to forward the electronic survey to all the members of the organization to
eliminate bias and to protect population confidentiality.
Selection of Sample Size
Sample size is determined by degree of precision (confidence interval) and accuracy
(confidence level) required for the responses to the survey questions. For this study,
confidence level is 95% and confidence interval is ±10%. Percentages below and above
50% will have least amount of variance. Therefore, sample for this study is based on 50%
point estimated for any question. Sample size needed to obtain the desired precision and
accuracy is approximately 100 (MaCorr Research Solutions, n.d.). Anticipating a 10%
response rate, survey will be sent to 1000 physicians (Survey sample size, n.d.).
Research Design
The research follows a descriptive method. “Descriptive method attempts to examine
situations in order to establish what is the norm, i.e. what can be predicted to happen
again under the same circumstances” (Walliman, 2011). It is versatile, fast, and
appropriate for this survey, as this technique is used for collecting existing circumstances
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in informed consent process in psychiatric research and determines the study population
perceptions.
The survey included a total of 19 questions: 7 were demographic questions answered
by the physicians (who have done psychiatric trials) work and 12 are related to
perceptions about the informed consent process in psychiatric research. In the 19
questions, 9 questions were closed ended questions (multiple choices) and 10 were
opinion questions that use a Likert rating scale. The survey may be found in Appendix C.
Human Subjects Protection
Prior to conducting the research or study or survey, an application for Review and
Approval to conduct research or survey involving human subjects was submitted to the
College of Health and Human Services Human Subjects Review Committee (CHHSHSRC) at Eastern Michigan University.
The CHHS-HSRC approved the study to conduct the survey on January 15, 2013,
along with the research-related documents like research proposal, Informed Consent form
and Survey Questionnaire (Appendix A: College of Health and Human Services Human
Subjects Review Committee Approval Letter).
All the potential participants were informed clearly about the purpose of the study,
procedure for responding to the survey, voluntariness and withdrawal, protecting the
rights of the participant by means of an Online Survey Consent Form. (Appendix B:
Survey Completion Request or Online Survey Consent Form or Email Survey).
Informed consent form or Online Survey Consent Form was forwarded electronically
along with the survey to all the members of Michigan Psychiatric Society. By filling out
21
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the survey, participant has agreed to the conditions of Online Survey Consent Form. If
the potential participants decided to participate, they could withdraw at anytime; their
participation was purely voluntary. There are no direct benefits or risks associated with
their participation, and all the responses to the survey are anonymous and confidential.
Method of Data Collection
The Michigan Psychiatric Society forwarded the survey to all members (potential
participants) of their organization in the form of a link entitled "EMU SURVEY" in their
newsletter on 02/19/2013 following the approval of CHHS-HSRC. Once the participant
clicked the "EMU SURVEY" link, he or she was directed to another link "CLICK HERE
to read the informed consent form" along with the background information about the
survey. Participants were then directed to the survey link; by clicking on that link they
were directed to the survey. The survey instrument included the consent form along with
the 7 demographic questions (answered by the physicians, who have done psychiatric
trials) and 12 questions related to the perceptions of physicians about the informed
consent process in psychiatric research. After completing the required questions (survey),
the participant was directed to click the "submit" button, which submitted his or her
anonymous answers to the investigator. The data were collected using Google Docs.
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Chapter 5: Results
Out of all the participants invited to the survey, only one participant successfully
completed the survey. Although the survey was available for more than a month, no
additional responses were received.
The single respondent did identify him/herself to the researcher and agreed to be
interviewed by telephone. The respondent has participated in 1 to 2 psychiatric clinical
trials, in which he/she acted as an investigator or as a sub-investigator. He/she has used
informed consent survey method to assess the decision-making capacity of the subjects
participated in psychiatric clinical trials. The respondent has taken informed consent from
the subjects, instead of delegating to the lower level assistants. Informed consent was
retaken from the subjects who have acquired decision-making capacity during the course
of a trial, where surrogate consent was used initially. The respondent did not explain the
procedure again to the subjects who have short term memory loss; instead he/she showed
the informed consent and proceeded when the subject had agreed to a particular
procedure. He/she has recruited the subjects who have failed in decision-making
capacity.
The respondent believed that it is not important to assess the subject’s decisionmaking capacity before the informed consent process. He/she believed that explaining the
experimental methods (randomization, blinding) in detail to the psychiatric subjects may
be neglected as they have less capacity to comprehend. He/she also believed that retaking
of informed consent from subjects was neglected even though they regain the decisionmaking capacity during the course of a trial. Psychiatric subjects are simply expelled

23

Informed consent in Psychiatric Research
from the clinical trials other than psychiatric trials (e.g., diabetes), instead of providing
treatment options to them as it is difficult to get informed consent.
The respondent believed that informed consent process in psychiatric trials needs to
be changed. He/she strongly agreed that informed consent process can be more useful by
having more interactive sessions between the physician and patients before taking the
informed consent. The respondent agreed that the use of creative modes of explanation
(videos, artworks) can make the informed consent process more successful rather than
simply using the paper informed consent form. He/she also agreed that mock informed
consent sessions before the actual informed consent process can be useful because
subjects will understand what exactly the informed consent process is and this can be
more useful to the psychiatric subjects. The respondent also believed that providing
informed consent in the language understood by subjects will help.
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Chapter 6: Discussion
In the feedback from a single investigator, it seems that the following elements may
be neglected in informed consent process of psychiatric research:


Explaining experimental procedures (randomization, blinding) to subjects
during informed consent process



Retaking of informed consent from subjects after they retain decisionmaking capacity during course of trial



Psychiatric subjects are simply expelled from the clinical trials instead of
providing treatment options as it is difficult to take surrogate consent

Based on these preliminary data obtained from the survey, it is suggested that the
following element needs to be tailored in the informed consent process to make it more
successful:
Explain in detail about the trial procedure including experimental procedures
Every subject in the trial has a right to know about the trial procedure in detail. The
research coordinators or other staff may neglect the trial procedures as subjects may
refuse to participate in the trial if the procedure involves more risks. Even if the subjects
are mentally impaired, the researcher must try to provide detailed information as much as
he/she can. For example, if the trial is placebo-controlled, they should explain to subjects
in detail that they may receive a placebo which may not be helpful for them.
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More interactive sessions before actual consent process
Including more interactive sessions with the doctor before the informed consent
process makes the consent process easier. These interactive sessions help doctors to
determine whether the subject is understanding or not and also help to train the
subject about the research. Many new methods of description about the research can
be created based on the information explored in interactive sessions. These sessions
even allow the subject to get acquainted with the research circumstances.
Creative methods to comprehend information for subjects
Developing new methods for the mode of communicating information to the
psychiatric subjects is essential. Psychiatric patients understand well when we do it in
action. Describing to subjects about the trials by creating video clips, art works
(vignettes), and presentations may help subjects to understand more information.
Use language which is easily understood by the subjects
Explaining to subjects in the language understood by them makes them feel
comfortable, especially in case of psychiatric patients. In general, psychiatric patients
are incompetent, and describing the experimental procedures in a language other than
their native language makes it more complex and subjects feel stressed. Hence, use of
a language which is easily understood by the subject is vital.
Mock informed consent process
Conducting a mock informed consent process before the actual consent process
may be useful. This gives awareness to the subject about the informed consent
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process and allows the physicians to determine the loop holes in the procedure
involved and hence make necessary changes to make the informed consent process
suitable to the subjects.
Survey research is an important tool in the health care or clinical research field to
collect the important information or opinions of the healthcare professionals about a
particular issue or subject or matter or topic, which adds knowledge or finds solutions to
the existing problems. Without the participation of the healthcare professionals in the
survey, we are not able to find the solutions to the existing problems or issues, because
their opinion and knowledge matters (Katherine, 2011).
Physicians and health care professionals with their vast knowledge and experience are
good sources of information. Their opinions or suggestions are captured through the
medical surveys, where the input from the general population is not sufficient. However,
researchers have been concerned about the low response rates and the response rates for
physician surveys were on average 10% lower than the surveys involving non-physicians
(Emily, 2006).
In this research study, only one physician responded to the survey, which is a very
low response rate. Unfortunately, this low response has weakened the value of the survey.
Conducting surveys on medical professionals is difficult and different from conducting
surveys on the general population.
Possible reasons for very low response rate in physicians surveys


Questionnaire Fatigue: This is one of the main reasons for low response
rate, as physicians are overwhelmed from receiving tens to hundreds of
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questionnaire everyday from wide variety of sources. This glut simply
makes them ignore all questionnaires (Clare, 2011).


Busy Schedule: Completion of all the questionnaires received is very timeconsuming and difficult to perform during their busy schedules (Carolyn,
2010).



Topic of the survey may not be of their interest or uninteresting: One of
the main factors is interest; if the topic of survey is not part of their
interest they will not answer and will not even try to answer (Thorpe,
2011).

Well designed, well conducted, very useful surveys are getting lost in the ocean of
poorly designed questionnaires (Clare, 2011). How might one increase the response rate
in physician surveys?
Suggestions to increase the response rate in physician surveys (Clare, 2011)


By using a mixed mode of survey administration (combination of email,

mail, phone and fax)


By finding a more interesting questionnaire topic



By offering monetary incentives along with the survey



By using shorter questionnaires in the surveys



By contacting the physicians before sending the questionnaires and doing
a follow-up after sending out the questionnaire



By providing a second copy of the questionnaire to the non-respondents
during the follow-up process
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Implementation of successful techniques to improve the response is very important
because healthcare researchers often depend on the information gathered through the
healthcare surveys (Thorpe, 2011). "Cooperation theory would suggest that, if the
sampled physicians understood the importance of the survey, they would be more likely
to cooperate because there would be a benefit to themselves as well as the survey"
(Catherine, n.d.).
Limitations and Recommendations for Future Research
There are limitations to this study; the response rate was very low.
A similar study can be done or replicated with a wide range of healthcare
professionals, who have worked or have experience in psychiatric clinical trials. This
study tried to capture the perceptions of physicians who have experience in psychiatric
clinical trials, which is a select population. A broader population of healthcare
professionals would likely increase the response rate as well as wide range of perceptions
about the informed consent process in psychiatric research.
Surveys targeting the physicians are encountering low response rate, and researchers
are having hard time in obtaining a good response rate. Therefore, following techniques
which can increase the response rate in physician surveys can enhance the validity and
reliability of the results obtained, which in turn will enhance the usefulness of the survey
or the study conducted.
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Chapter 7: Conclusion
Through this study the investigator was hoping to find whether the elements of
informed consent were neglected in psychiatric research. The survey failed to provide the
information due to very low response rate. A single respondent’s answers indicate that
this may yet be a fruitful area of research if proper incentives could significantly increase
the response rate.
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Appendix A: College of Health and Human Services Human Subjects Review
Committee Approval Letter
Dear Sushma and Dr. Martin,
Congratulations! After careful review, your proposal "Physicians Satisfaction with
Informed Consent Process in Psychiatric Research" with its suggested revisions has been
approved by the College of Health and Human Services Human Subjects committee.
The current version of your paper is available here:
http://commons.emich.edu/cgi/preview.cgi?article=1098&context=chhs_hs
If any revisions become necessary in the future, use the Revise Submission link on the
above site and upload to your original file MS #1098.
We stress that you do not stray from your proposed plan. Good luck with your research
effort.
Sincerely,
Gretchen Dahl Reeves, PhD
Chair, CHHS-HSRC
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Appendix B: Survey Completion Request or Online Survey Consent Form or Email
Survey
Survey title:
Physician Satisfaction with Informed Consent Process in Psychiatric Research
Dear Doctor,
As a part of my master’s thesis, I am requesting your participation in a survey.
You are being invited to complete this survey about "Physician Satisfaction with
Informed Consent Process in Psychiatric Research". This research project is done by
Sushma Polavarapu from Eastern Michigan University.
The purpose of this research study is to determine the perceptions of physicians
on the elements of informed consent that might be neglected in the psychiatric research
and on what additional elements might improve the informed consent process in
psychiatric trials.
The survey includes 19 multiple choice questions about the informed consent
process. The survey should take approximately 15 minutes to complete. Your
participation is voluntary and you may choose not to participate. If you decide to
participate in this research survey, you may withdraw at anytime. Your participation and
responses will be kept anonymous. Your participation in the study will conclude, once
you have completed and submitted the survey.
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As a researcher I respect your rights to privacy and I will keep the survey results
confidential. I am not collecting any kind of personal identifiable information during the
course of this survey.
The data will be collected via the online survey (Google Docs) and the results of
the survey will be held by me. [Privacy Policy of Google
http://www.google.com/intl/en/policies/privacy/]
The results of the survey will be held on a password protected personal laptop:
only I have access to it. All raw data will be deleted upon submission of my thesis.
There are no foreseeable risks to you by completing this survey, as all results will
be kept completely confidential. There are no direct benefits associated with your
participation, but your input is valued. If you decide to participate, you may change your
mind at any time and withdraw from the study without any consequences. There is no
penalty for discontinuing at any time during the study and all information will remain
confidential.
Results will be presented in aggregate form only. No names or individually
identifying information will be revealed. Results may be presented at research meetings
and conferences, in scientific publications, and as part of a master's thesis being
conducted by the principal investigator.
Please click on the following link to access the survey:
https://docs.google.com/spreadsheet/embeddedform?formkey=dHFBWVlPZlk4WC15cH
hRNXRjVmxPR2c6MQ
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By clicking on the link above, you are indicating that:


You have read all of the above information about this research study, including
the research procedures, possible risks, side effects, and the likelihood of any
benefit.



You understand the content and meaning of this information.



Your questions, at this time, have been answered.



You consent and agree to participate voluntarily in the survey.

I hope you will respond. Thank you in advance for your participation.
Sushma Polavarapu, Clinical Research Administration, Eastern Michigan University
If you have any questions concerning your participation in this study now or in the
future, you may contact Dr. Irwin Martin, Associate Professor, Health Sciences, Eastern
Michigan University, imartin2@emich.edu.
"This research protocol and informed consent document has been reviewed and
approved by the Eastern Michigan University College of Health and Human
Services Human Subjects Review Committee for use from January 15, 2013 to
January 14, 2014. If you have questions about the approval process, please contact
Dr. Gretchen Dahl Reeves (Chair, College of Health and Human Services Human
Subjects Review Committee, 734-487-3236, greeves@emich.edu)."
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Appendix C: Survey
Survey title:
Physician Satisfaction with Informed Consent Process in Psychiatric Research
Survey Questions
1. In how many clinical trials have you participated in which you were an investigator
or a sub-investigator?


None



1-2



3-5



6-10



>10

2. How many psychiatric clinical trials have been or are being conducted under your
supervision as an investigator or a sub-investigator?


none



1-2



2-5



>5

3. If you have conducted any psychiatric research, which of the following tools is used to
assess the decision-making capacity of the subjects in psychiatric trials? (Select all that
apply)


MacArthur Competence Assessment Tool For Clinical Research(Mac CAT-CR)
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Informed consent survey



Vignette method



other(Please specify)

4. In psychiatric clinical trials, conducted under your investigation, is informed consent
taken by you or delegated to any lower level assistant (usually coordinator)?


Taken by yourself



Delegated to Lower level assistant



Delegated to lower level assistant in your presence



none

5. In psychiatric clinical trials, conducted under your investigation, is the informed
consent is re-taken by the subjects who acquired decision making capacity in the course
of the trial, where surrogate consent was initially used?


Re-taken by the subjects



Not re-taken



Just oral consent taken

6. In psychiatric clinical trials, conducted under your investigation, are the trial procedure
and informed consent process explained again in detail to the short-term memory loss
patient, if he/she refuses to take certain procedures (phlebotomy, MRI scan) or are the
procedures just done in coercion with the authorized representative’s permission?


Explained again and again till they understand and agree



Explained once and proceeded in coercion with permission of representative
43

Informed consent in Psychiatric Research


Just showed the informed consent and proceeded when they agreed and failed to
explain the procedure again



Just proceeded even if they are not willing to participate

7. In psychiatric clinical trials, conducted under your investigation, did you recruit
subjects who failed in decision making capacity (even though it is not an exclusion
criterion), as it might be difficult to get the surrogate’s consent due to many rules and
regulations?


Recruited



Not recruited



Recruited if the surrogate is ready



Not recruited even if patient with surrogate is willing to participate, as it is
difficult to get surrogate consent.

8. Do you have any concerns regarding the enrollment of mentally-impaired patients in
clinical research?


No, I feel this is appropriate



Yes, never enroll mentally-impaired patients in research



Yes, enroll them with certain special precautions



Yes, enroll them only with legally authorized representative

9. In psychiatric trials, it is important to assess the subject’s decision-making capacity
before the informed consent process.


Strongly agree
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Agree



Neutral



Disagree



Strongly disagree

10. Understanding, appreciation, reasoning and choice are the best standards to test the
decision-making capacity of the psychiatric patient.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree

11. Explaining the experimental methods (randomization, blind) may be neglected in the
informed consent process involving psychiatric patients as the patient has less capacity to
comprehend.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree
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12. Repeating the information (in case of short term memory) may be neglected in the
informed consent process involving psychiatric patients as it is difficult to explain again
and again.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree

13. Re-taking informed consent when the subject regains decision making capacity in the
course of the trial may be neglected in the informed consent process involving psychiatric
patients as they feel it is less important as they have taken it already.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree

14. Expelling the subject from the study if he/she is incompetent (even though it is not an
exclusion criterion) is appropriate instead of helping them to improve their health
condition by using proxies as there are many rules and regulations.


Strongly agree



Agree
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Neutral



Disagree



Strongly disagree

15. Do you think the informed consent process for psychiatric patients needs to be
changed?


Yes



No

16. Providing more interactive sessions before the informed consent process (between
physician and subject) and information about the trial make the informed consent process
more suitable and useful for psychiatric patients.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree

17. Use of creative modes for explanation (as psychiatric patients understand better in
practical rather than in theory, so videos, artworks etc. can be used) make the informed
consent process more suitable and useful for psychiatric patients.


Strongly agree



Agree



Neutral
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Disagree



Strongly disagree

18. Inclusion of Mock Informed consent process ( help to determine the loop holes in
present process used and help to make changes as required) before the actual consent
process makes the informed consent process more suitable and useful for psychiatric
patients.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree

19. Providing informed consent in more comprehensible language makes the informed
consent process more suitable and useful for psychiatric patients.


Strongly agree



Agree



Neutral



Disagree



Strongly disagree
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